Costly drugs to weigh on U.S. employers’ expenses in 2018: survey
(Reuters) – U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer. continue to full story
